跳至主要内容
临床试验/NL-OMON43970
NL-OMON43970招募中2 期

Human intestinal ischemia and reperfusion - Human intestinal IR

niversiteit Maastricht0 个研究点目标入组 69 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult patients (18 years of age and older) undergoing major upper abdominal surgery
  • o Whipple-procedure or pylorus preserving pancreatico duodenectomy (PPPD)
  • o Ileo-Jejunal bypass surgery
  • o Roux-en-Y gastric bypass
  • o Total gastrectomy
  • o Hepatico jejunostomy
  • o Pancreaticojejunostomy (Frey*s procedure)
  • Patients who have given an informed consent

排除标准

  • <18 years of age or older but no proper understanding of the research proposal
  • Inflammatory bowel disease
  • Celiac disease
  • Acute major abdominal procedures
  • Patients who have refused informed consent;For the population who will receive tranexamic acid additional exclusion criteria have been formulated: ;Active or history of thrombo-embolic disorders such as deep venous thrombosis, pulmonary embolism or cerebral embolism
  • History of blood coagulation disorder (hypercoagulation state)
  • Subarachnoid hemorrhage
  • Disseminated intravascular coagulation (DIS)
  • Severe renal insufficiency: i.e. serum kreatinine >150 µmol/L
  • History of convulsions
  • Known hypersensitivity of allergy for tranexamic acid
  • Simultaneous use of thrombolytics (e.g. alteplase, streptokinase)
  • Simultaneous use of hormonal anticonceptives or other substances that induce hemostasis. ;For the population who will receive doxycycline additional exclusion criteria have been formulated: ;Known hypersensitivity of allergy for tetracyclines.
  • Severe liver function disorder i.e. ASAT or ALAT or AF or γ-GT >150 U/L whether or not combined with severe renal insufficiency: i.e. serum kreatinine >150 µmol/L.
  • Severe renal insufficiency: i.e. serum kreatinine >150 µmol/L.
  • Myasthenia gravis
  • Simultaneous usage (or just before or after administration of doxycycline) of oral retinoids or substances containing metalions (such as antagel or ironpreparations)
  • Simultaneous use of methoxyflurane (anesthetic) or oral contraceptives
  • Bodyweight beneath 50 kg
  • History of blood coagulation disorder (inert hypocoagulation state)
  • Pregnancy or lactating

研究者

相似试验